Samsung Bioepis opens Korea HQ for biologics

The building was completed in December 2020

Samsung Bioepis has announced the opening of its headquarters in Korea’s ‘Bio Cluster’ of Songdo, located in the Incheon Free Economic Zone (IFEZ), a specially designated economic zone in the city of Incheon. The site is approximately 52,000 sqft and will be the hub for the company’s development of biologic medicines.

“We are very excited to be opening our new headquarters which will serve as the foundation for the company’s next stage of growth. Our colleagues who were previously stationed in two campuses in Korea will be working together at the new headquarters to accelerate our passion for health," said Christopher Hansung Ko, President and CEO of Samsung Bioepis. “With the new office equipped with the state-of-the-art laboratories, we look forward to providing our high-quality biologic medicines with more agility and with stringent quality control so that patients around the world can have access to our proven medicines more quickly and more widely available.”

The building will house approximately 1,000 employees, who will be working in the laboratory and office space. Attached to the main building is a three-story ‘welfare centre’ which includes a cafeteria, a gymnasium and a fitness centre for employees to enjoy. It also has an onsite childcare centre to support employees with young children.

Companies